A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation-Reference-Cited by-同舟云学术

A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation

Published:2007-03 Issue:8 Volume:44 Page:1835-1844
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Nilsson Sara C.,Karpman Diana,Vaziri-Sani Fariba,Kristoffersson Ann-Charlotte,Salomon Rémi,Provot Francois,Fremeaux-Bacchi Veronique,Trouw Leendert A.,Blom Anna M.

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference35 articles.

1. Inherited complete factor I deficiency associated with systemic lupus erythematosus, higher susceptibility to infection and low levels of factor H;Amadei;Scand. J. Immunol.,2001

2. Inhibition of complement components C3 and C4 by cadralazine and its active metabolite;Andersson;Eur. J. Clin. Pharmacol.,1991

3. CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b;Blom;Mol. Immunol.,2003

4. Complement factor I deficiency with recurrent aseptic meningitis;Bonnin;Arch. Intern. Med.,1993

5. Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease;Caprioli;Hum. Mol. Genet.,2003

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic investigation of Nordic patients with complement-mediated kidney diseases;Frontiers in Immunology;2023-09-07

2. Complement factor I: Regulatory nexus, driver of immunopathology, and therapeutic;Immunobiology;2023-09

3. An assessment of prevalence of Type 1 CFI rare variants in European AMD, and why lack of broader genetic data hinders development of new treatments and healthcare access;PLOS ONE;2022-09-06

4. Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls;Journal of Clinical Medicine;2022-06-10

5. A novel missense mutation in complement factor I predisposes patients to atypical hemolytic uremic syndrome: a case report;Journal of Medical Case Reports;2022-03-04